Omega Fund V Gp, L.p. - Net Worth and Insider Trading

Omega Fund V Gp, L.p. Net Worth

The estimated net worth of Omega Fund V Gp, L.p. is at least $270 Million dollars as of 2024-07-08. Omega Fund V Gp, L.p. is the 10% Owner of Nuvation Bio Inc and owns about 23,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $127 Million. Omega Fund V Gp, L.p. is the Director of Morphic Holding Inc and owns about 2,086,071 shares of Morphic Holding Inc (MORF) stock worth over $66 Million. Omega Fund V Gp, L.p. is also the 10% Owner of Nuvation Bio Inc and owns about 20,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $62 Million. Besides these, Omega Fund V Gp, L.p. also holds Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) . Details can be seen in Omega Fund V Gp, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Omega Fund V Gp, L.p. has not made any transactions after 2022-04-05 and currently still holds the listed stock(s).

Transaction Summary of Omega Fund V Gp, L.p.

To

Omega Fund V Gp, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Omega Fund V Gp, L.p. owns 7 companies in total, including Kronos Bio Inc (KRON) , Gossamer Bio Inc (GOSS) , and Morphic Holding Inc (MORF) among others .

Click here to see the complete history of Omega Fund V Gp, L.p.’s form 4 insider trades.

Insider Ownership Summary of Omega Fund V Gp, L.p.

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2020-10-14 10 percent owner
GOSS Gossamer Bio Inc 2019-09-20 10 percent owner
MORF Morphic Holding Inc 2021-04-28 director
LIMIT LIMIT 2019-05-09 10 percent owner
LIMIT LIMIT 2019-04-12 10 percent owner
LIMIT LIMIT 2018-07-02 10 percent owner
LIMIT LIMIT 2022-04-05 10 percent owner

Omega Fund V Gp, L.p. Latest Holdings Summary

Omega Fund V Gp, L.p. currently owns a total of 6 stocks. Among these stocks, Omega Fund V Gp, L.p. owns 23,457,340 shares of Nuvation Bio Inc (NUVB) as of December 7, 2021, with a value of $127 Million and a weighting of 47.2%. Omega Fund V Gp, L.p. owns 2,086,071 shares of Morphic Holding Inc (MORF) as of April 28, 2021, with a value of $66 Million and a weighting of 24.59%. Omega Fund V Gp, L.p. also owns 20,457,340 shares of Nuvation Bio Inc (NUVB) as of April 5, 2022, with a value of $62 Million and a weighting of 22.95%. The other 3 stocks Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) have a combined weighting of 5.26% among all his current holdings.

Latest Holdings of Omega Fund V Gp, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NUVB Nuvation Bio Inc 2021-12-07 23,457,340 5.44 127,490,643
MORF Morphic Holding Inc 2021-04-28 2,086,071 31.84 66,420,501
NUVB Nuvation Bio Inc 2022-04-05 20,457,340 3.03 61,985,740
GOSS Gossamer Bio Inc 2019-09-20 6,553,416 1.08 7,077,689
KRON Kronos Bio Inc 2020-10-14 3,818,283 1.15 4,391,025
TRVI Trevi Therapeutics Inc 2019-05-09 1,063,408 2.58 2,743,593

Holding Weightings of Omega Fund V Gp, L.p.


Omega Fund V Gp, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 4 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Nuvation Bio Inc is the sale of 1,400,000 shares on December 7, 2021, which brought Omega Fund V Gp, L.p. around $14 Million.

According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 38 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 0 buys and 38 sells. The most-recent trade in Morphic Holding Inc is the sale of 10,704 shares on April 28, 2021, which brought Omega Fund V Gp, L.p. around $593,216.

According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nuvation Bio Inc is the sale of 2,500,000 shares on April 5, 2022, which brought Omega Fund V Gp, L.p. around $14 Million.

More details on Omega Fund V Gp, L.p.'s insider transactions can be found in the Insider Trading History of Omega Fund V Gp, L.p. table.

Insider Trading History of Omega Fund V Gp, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Omega Fund V Gp, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Omega Fund V Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund V Gp, L.p. is -19.89%. GuruFocus also compares Omega Fund V Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund V Gp, L.p. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Omega Fund V Gp, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Omega Fund V Gp, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.39 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.44 LIMIT LIMIT LIMIT LIMIT LIMIT

Omega Fund V Gp, L.p. Ownership Network

Ownership Network List of Omega Fund V Gp, L.p.

No Data

Ownership Network Relation of Omega Fund V Gp, L.p.

Insider Network Chart

Omega Fund V Gp, L.p. Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Omega Fund V Gp, L.p. is the 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Omega Fund V Gp, L.p. made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 50,347 shares made by Jorge Dimartino , a net sale of 30,323 shares made by Christopher Dinsmore , and a net purchase of 5,351,696 shares made by Norbert W Bischofberger .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 3,620,640 shares, with a net purchase of 3,620,640 shares. During the past 18 months, 141,498 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,210,198 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Omega Fund V Gp, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Omega Fund V Gp, L.p.. You might contact Omega Fund V Gp, L.p. via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.

Discussions on Omega Fund V Gp, L.p.

No discussions yet.